INTRODUCTION: Experience with use of real-time continuous @entity413 monitoring systems (RT-CGMS) in teenagers with @entity1723 is limited, and in unselected groups of young @entity1 did not show improvement in metabolic control. AIM OF THE STUDY: The objective of this study was to assess short-term RT-CGMS usage in teenagers with type 1 @entity6 , in terms of possibility to improve metabolic control and acceptance of the system. MATERIAL AND METHODS: 40 subjects, aged 14.5  2 years on insulin pump therapy were included in the study. Mean @entity6 duration was 6  3 years and HbA1c level before the study was 8.4  1.5%. The analysis was based on single 5-6 days long sensor usage, connected with education of the family. We analysed several parameters of glycaemic variability during the study, and HbA(1)c level before and 2 months after the study. @entity1 ' satisfaction was assessed on the basis of a questionnaire. RESULTS: HbA(1)c level in the whole teenagers group decreased insignificantly by 0.3%; from 8.4  1,% to 8.1  1.6%. In 24 (60%) @entity1 we showed improvement in HbA(1)c by at least 0.5% (mean 0.9%, from 8.1  1.3% to 7.2  1.2%; p=0.03). HbA(1)c level was slightly higher in @entity1 than in @entity1 at the beginning of the study and a greater reduction in HbA(1)c was shown for @entity1 . After two months the difference was significant: 8.6  1.9% in @entity1 vs. 7.6  1.3% in @entity1 , p=0.03. In the group with HbA(1)c decrease and in @entity1 we demonstrated improvement in mean glycaemia and glycaemic variability parameters on the last day of the sensor usage, compared to the first day. In @entity1 however, increased AUC <70 mg/dl/ min was noticed. The @entity1 from the group with HbA(1)c decrease reported fewer problems with system calibration: 3.2 vs. 2.6 score, p=0.03. This group also reported higher satisfaction score connected with new knowledge: 4.0 vs. 3.5, and with quality of life: 4.1 vs. 3.6. CONCLUSIONS: Short-term usage of RT-CGMS, combined with satisfaction questionnaire performed in teenagers with @entity1723 can be useful in defining the group of young @entity1 who can benefit from RT-CGMS usage in long-term metabolic control improvement.

[Usefulness of short-term usage of real time continuous @entity413 monitoring system in achieving metabolic control improvement in adolescents with type 1 XXXX ].

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'girls', 'boys'] @entity1723 :: ('MESH:D003922', 'Disease') :: ['diabetes type 1'] @entity413 :: ('MESH:D005947', 'Chemical') :: ['glucose'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes']
@entity6 :: (MESH:D003920,Disease) :: ['diabetes']
